13F
中

UTMD UTAH MEDICAL PRODUCTS INC

2026Q1 · CUSIP 917488108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
118
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
64
Δ whales
+3
Inst. holding value
$139M
New positions
14
Closed positions
13
Price momentum (1Q)
-1.6%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+3 · h=81 2018Q2: Δ+11 · h=92 2018Q3: Δ+0 · h=92 2018Q4: Δ-4 · h=88 2019Q1: Δ+6 · h=94 2019Q2: Δ+5 · h=99 2019Q3: Δ+0 · h=99 2019Q4: Δ-3 · h=96 2020Q1: Δ-6 · h=90 2020Q2: Δ+3 · h=93 2020Q3: Δ-8 · h=85 2020Q4: Δ-8 · h=77 2021Q1: Δ+2 · h=79 2021Q2: Δ-11 · h=68 2021Q3: Δ+5 · h=73 2021Q4: Δ+7 · h=80 2022Q1: Δ+6 · h=86 2022Q2: Δ-10 · h=76 2022Q3: Δ+3 · h=79 2022Q4: Δ+4 · h=83 2023Q1: Δ+5 · h=88 2023Q2: Δ+3 · h=91 2023Q3: Δ+2 · h=93 2023Q4: Δ-3 · h=90 2024Q1: Δ+12 · h=102 2024Q2: Δ+0 · h=102 2024Q3: Δ+9 · h=111 2024Q4: Δ+1 · h=112 2025Q1: Δ-2 · h=110 2025Q2: Δ+1 · h=111 2025Q3: Δ+6 · h=117 2025Q4: Δ+0 · h=117 2026Q1: Δ+1 · h=118 2018Q1: holders=81 2018Q2: holders=92 2018Q3: holders=92 2018Q4: holders=88 2019Q1: holders=94 2019Q2: holders=99 2019Q3: holders=99 2019Q4: holders=96 2020Q1: holders=90 2020Q2: holders=93 2020Q3: holders=85 2020Q4: holders=77 2021Q1: holders=79 2021Q2: holders=68 2021Q3: holders=73 2021Q4: holders=80 2022Q1: holders=86 2022Q2: holders=76 2022Q3: holders=79 2022Q4: holders=83 2023Q1: holders=88 2023Q2: holders=91 2023Q3: holders=93 2023Q4: holders=90 2024Q1: holders=102 2024Q2: holders=102 2024Q3: holders=111 2024Q4: holders=112 2025Q1: holders=110 2025Q2: holders=111 2025Q3: holders=117 2025Q4: holders=117 2026Q1: holders=118 -12 -6 +0 +6 +12 6193124 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
20.5
EPS (TTM)
$3.38
EPS YoY
-10.8%
Revenue (TTM)
$0.0B
Revenue YoY
-4.4%
Quarterly Revenue & EPS (4Y)
2022-06-30: $13M 2022-09-30: $13M 2022-12-31: $14M 2023-03-31: $13M 2023-06-30: $13M 2023-09-30: $13M 2023-12-31: $12M 2024-03-31: $11M 2024-06-30: $10M 2024-09-30: $10M 2024-12-31: $9M 2025-03-31: $10M 2025-06-30: $10M 2025-09-30: $10M 2025-12-31: $9M 2026-03-31: $9M 2022-06-30: EPS 1.12 2022-09-30: EPS 1.18 2022-12-31: EPS 1.25 2023-03-31: EPS 1.16 2023-06-30: EPS 1.15 2023-09-30: EPS 1.08 2023-12-31: EPS 1.18 2024-03-31: EPS 1.09 2024-06-30: EPS 0.98 2024-09-30: EPS 1.03 2024-12-31: EPS 0.86 2025-03-31: EPS 0.92 2025-06-30: EPS 0.94 2025-09-30: EPS 0.82 2025-12-31: EPS 0.80 2026-03-31: EPS 0.82 0M 7M 14M $M 0.00 0.69 1.38 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 15 2023-03-31: PE 18.92023-06-30: PE 18.82023-09-30: PE 17.42023-12-31: PE 15.12024-03-31: PE 14.82024-06-30: PE 15.22024-09-30: PE 14.92024-12-31: PE 152025-03-31: PE 14.22025-06-30: PE 14.52025-09-30: PE 15.42025-12-31: PE 18.22026-03-31: PE 18.7 13 16 20 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)